Chugai Pharmaceutical Co., Ltd.

TSE-4519

Overview Financials Investor Relations Estimates Ownership Industry Dividends Modeling Filings

Income Statement	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Operating Revenues						588,896	633,314	802,836	1,039,247	974,493	936,976
Other Revenues, Total	—					97,288	153,632	196,923	220,699	136,874	147,594
Total Revenues						686,184	786,946	999,759	1,259,946	1,111,367	1,084,570
Total Revenues % Chg.						18.4%	14.7%	27%	26%	-11.8%	-12.8%
Cost of Goods Sold, Total						266,071	273,465	338,147	476,251	413,306	331,206
Gross Profit						420,113	513,481	661,612	783,695	698,061	753,364
Selling General & Admin Expenses, Total						101,574	94,401	102,416	100,760	112,580	108,201
R&D Expenses						107,942	117,850	137,299	149,626	174,868	171,722
Other Operating Expenses	—	—	—	—	—	—	—	—	—	-28,561	-13,018
Other Operating Expenses, Total						209,516	212,251	239,715	250,386	258,887	266,905
Operating Income						210,597	301,230	421,897	533,309	439,174	486,459
Interest Expense, Total						-125	-62	-48	-61	-27	-12
Interest And Investment Income				—		545	—	—	52	4,674	2,408
Net Interest Expenses						420	-62	-48	-9	4,647	2,396
Currency Exchange Gains (Loss)		—	—	—	—	—	—	—	—	—	—
Other Non Operating Income (Expenses)		—				-3,124	-2,980	-2,464	-2,134	—	—
EBT, Excl. Unusual Items						207,893	298,188	419,385	531,166	443,821	488,855
Asset Writedown		—	—	—	—	—	—	—	—	—	—
EBT, Incl. Unusual Items						207,893	298,188	419,385	531,166	443,821	488,855
Income Tax Expense						50,333	83,455	116,390	156,737	118,349	133,814
Earnings From Continuing Operations						157,560	214,733	302,995	374,429	325,472	355,041
Minority Interest						—	—	—	—	—	—
Net Income						157,560	214,733	302,995	374,429	325,472	355,041
Net Income to Common Incl Extra Items						157,560	214,733	302,995	374,429	325,472	355,041
Net Income to Common Excl. Extra Items						157,560	214,733	302,995	374,429	325,472	355,041
Total Shares Outstanding						1,642.6	1,643.9	1,644.3	1,645	1,645.3	1,645.5
Weighted Avg. Shares Outstanding						1,642.1	1,643.4	1,644.2	1,644.8	1,645.2	1,645.3
Weighted Avg. Shares Outstanding Dil						1,644.5	1,645.1	1,645.2	1,645.3	1,645.5	1,645.6
EPS						95.9	130.7	184.3	227.6	197.8	215.8
EPS Diluted						95.8	130.5	184.2	227.6	197.8	215.8
EBITDA						236,998	331,606	452,765	564,743	470,914	518,099
Effective Tax Rate						24.2%	28%	27.8%	29.5%	26.7%	27.4%